Mark A. Sirgo - 09 Dec 2021 Form 4 Insider Report for BIOMERICA INC (BMRA)

Reporting relationship: Director
Issuer ticker: BMRA
Reported as of: 09 Dec 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Dec 2021, 17:02:10 UTC
Prior SEC filing: 06 Dec 2021
Next SEC filing: 31 Jan 2022
Source filing: View source filing
Reporting owner signature: /s/Mark Sirgo

Key filing fact

Mark A. Sirgo filed Form 4 for BIOMERICA INC (BMRA) on 10 Dec 2021.

Key facts

This page summarizes Mark A. Sirgo's Form 4 filing for BIOMERICA INC (BMRA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 10 Dec 2021, 17:02.

Change

Previous filing in this sequence was filed on 06 Dec 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BMRA holding

Common stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 8,700
Date: 09 Dec 2021
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BMRA transaction Derivative

Non-qualified stock option

Award

Transaction value
Shares: +25,000
Change %: +17%
Price
Shares after: 170,000
Date: 09 Dec 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 25,000
Exercise price: $4.46
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Not applicable

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .